Chemotherapy

Modernizing Dated Approaches to Oncology Care

FivepHusion

Biosensors

The Partnerships Powering Next-Gen Oncology Care

Olivia Newton-John Cancer Research Institute

Oncology

Celebrating a Decade of Oncology Innovation at ONJ

Olivia Newton-John Cancer Research Institute

Melanoma

Understanding the Challenges in Tackling Melanoma and Other Forms of Cancer

Olivia Newton-John Cancer Research Institute

Oncology

Up Close and Personal with Scientists on the Cutting Edge of Melanoma Research

Olivia Newton-John Cancer Research Institute

Oncology Trials

Navigating the Complex Landscape of Oncology Trials

Colin Hayward, MB BS

Ergomed

Bioassays

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Anke Hartung, Ph.D.,

Tanvex CDMO

Chronic Diseases

Transforming the Management of Chronic Diseases with Biosimilars

Hugo Sotelo; Jorge Catella

Biosidus

Protein Degradation

PROTACS: Upgrading Small Molecule Inhibitors

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Clinical Trials

Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators

Dave Selkirk

Ergomed

Vaccines

Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines

David Dodd; Mark Newman, Ph.D.

GeoVax Inc.

Microbiome

Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses

Stacy Burns-Guydish, Ph.D.

List Labs

Cell Therapy

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

Sarah Meeks, Ph.D.

MaxCyte

Oncology

Addressing Cancer Therapy Resistance by Targeting Translational Regulation

Steve Worland, Ph.D.

eFFECTOR

Tumor Microenvironment

Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies

Gil Efron

Purple Biotech

Bone Regeneration

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

Denis Dufrane, M.D., Ph.D.

Collaboration

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

Anima Biotech Inc.

Immuno-Oncology

Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology

Dan Passeri, M.Sc., J.D.

Cue Biopharma